tDCS and Speech Therapy in Aphasia Treatment: A Multicenter Comparative Study of Efficacy

21 September 2025 : Clinical Research

Zofia Twardochleb

^{ABCDEF 1}, Marta Szczepańska

^{ABCDEF 1}, Maciej M. Miś

^{CEF 2}, Marcin Miś

^{CEF 2}, Adam Druszcz

^{DEF 3,4}, Małgorzata Paprocka-Borowicz

^{ADEG 5,6*}, Joanna Rosińczuk

^{ADEFG 7}

DOI: 10.12659/MSM.950237

Med Sci Monit 2025; 31:e950237

Authors information Article notes Copyright and License information

Introduction Material and Methods Results Discussion Conclusions References

Related articles Order reprints Share article Share by email

View HTML version

Table 1 Characteristics of study patients.

Variable	Group I (tDCS)	Group II (SLT)	Group III (tDCS+SLT)	Total (n=90)	p-value
	30	30	30	90	–
	53.0±16.0	53.7±17.9	54.0±14.4	53.6±16.1	0.91
	18–75	19–82	18–77	18–82	–
	20/10	18/12	18/12	56/34	0.84
					0.73
Primary	1 (3.3%)	3 (10.0%)	3 (10.0%)	7 (7.8%)
Secondary	16 (53.3%)	16 (53.3%)	18 (60.0%)	50 (55.6%)
Higher	8 (26.7%)	7 (23.4%)	5 (16.7%)	20 (22.2%)
					0.77
Employed	18 (60.0%)	15 (50.0%)	15 (50.0%)	48 (53.3%)
Retired/disability	11 (36.7%)	13 (43.3%)	14 (46.7%)	38 (42.2%)
Unemployed	1 (3.3%)	2 (6.7%)	1 (3.3%)	4 (4.4%)
					0.39
Ischemic stroke	18 (60.0%)	13 (43.4%)	21 (70.0%)	52 (57.8%)
TBI	8 (26.7%)	16 (53.3%)	9 (30.0%)	33 (36.7%)
Stroke+TBI	4 (13.3%)	1 (3.3%)	0 (0.0%)	5 (5.5%)
	1.4±0.6	1.3±0.5	1.5±0.9	1.4±0.6	0.67
tDCS – transcranial direct current stimulation; SLT – speech and language therapy; TBI – traumatic brain injury.

Back to the Article